C.T. Viswanathan

6.8k total citations · 4 hit papers
31 papers, 5.2k citations indexed

About

C.T. Viswanathan is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Immunology. According to data from OpenAlex, C.T. Viswanathan has authored 31 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in C.T. Viswanathan's work include Biosimilars and Bioanalytical Methods (8 papers), Pharmaceutical studies and practices (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). C.T. Viswanathan is often cited by papers focused on Biosimilars and Bioanalytical Methods (8 papers), Pharmaceutical studies and practices (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). C.T. Viswanathan collaborates with scholars based in United States, United Kingdom and Switzerland. C.T. Viswanathan's co-authors include Vinod P. Shah, Jerome P. Skelly, Avraham Yacobi, Iain J. McGilveray, Kamal K. Midha, Thomas Layloff, R.D. McDowall, C. E. Cook, Russell Weiner and Anthony J. DeStefano and has published in prestigious journals such as Brain Research, Clinical Chemistry and International Journal of Pharmaceutics.

In The Last Decade

C.T. Viswanathan

31 papers receiving 4.8k citations

Hit Papers

Bioanalytical Method Validation—A Revisit with a Decade o... 1991 2026 2002 2014 2000 1992 2007 1991 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bioanalytical Method Validation—A Revisit with a Decade of Progress
    2000 1.4k citations Vinod P. Shah, Kamal K. Midha et al. Pharmaceutical Research profile →
  2. Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic Studies
    1992 1.0k citations Vinod P. Shah, Kamal K. Midha et al. Journal of Pharmaceutical Sciences profile →
  3. Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays
    2007 667 citations C.T. Viswanathan, Surendra K. Bansal et al. Pharmaceutical Research profile →
  4. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies
    1991 556 citations Vinod P. Shah, K.K. Midha et al. European Journal of Drug Metabolism and Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.T. Viswanathan United States 20 1.4k 1.1k 1.0k 843 735 31 5.2k
Jerome P. Skelly United States 27 1.1k 0.8× 741 0.7× 646 0.6× 799 0.9× 648 0.9× 70 4.7k
Avraham Yacobi United States 32 1.3k 0.9× 1.2k 1.1× 565 0.6× 905 1.1× 733 1.0× 128 6.0k
Kamal K. Midha Canada 29 1.1k 0.7× 894 0.8× 550 0.5× 763 0.9× 771 1.0× 75 5.2k
Iain J. McGilveray Canada 15 789 0.5× 847 0.8× 426 0.4× 610 0.7× 524 0.7× 29 3.3k
C. E. Cook United States 30 1.1k 0.8× 1.1k 1.0× 296 0.3× 598 0.7× 517 0.7× 108 4.6k
R.D. McDowall United Kingdom 15 691 0.5× 576 0.5× 324 0.3× 760 0.9× 697 0.9× 78 3.1k
Mohammed Jemal United States 34 1.4k 1.0× 427 0.4× 522 0.5× 707 0.8× 1.6k 2.2× 134 3.8k
C.M. Chavez-Eng United States 18 1.4k 1.0× 1.3k 1.2× 219 0.2× 1.4k 1.6× 1.7k 2.3× 31 6.2k
U. Kristina Walle United States 45 2.4k 1.7× 910 0.8× 209 0.2× 476 0.6× 554 0.8× 95 6.9k
Eric Woolf United States 32 572 0.4× 785 0.7× 499 0.5× 491 0.6× 566 0.8× 96 2.7k

Countries citing papers authored by C.T. Viswanathan

Since Specialization
Citations

This map shows the geographic impact of C.T. Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.T. Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.T. Viswanathan more than expected).

Fields of papers citing papers by C.T. Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.T. Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.T. Viswanathan. The network helps show where C.T. Viswanathan may publish in the future.

Co-authorship network of co-authors of C.T. Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of C.T. Viswanathan. A scholar is included among the top collaborators of C.T. Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.T. Viswanathan. C.T. Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garofolo, Fabio, Brian Booth, C.T. Viswanathan, et al.. (2012). Conference Report: Us Fda/Ema Harmonization of Their Bioanalytical Guidance/Guideline And Activities of The Global Bioanalytical Consortium. Bioanalysis. 4(3). 231–236. 15 indexed citations
2.
Viswanathan, C.T.. (2010). Regulatory Observations in Bioanalytical Determinations. Bioanalysis. 2(7). 1325–1329. 6 indexed citations
3.
Fast, Douglas M., Marian Kelley, C.T. Viswanathan, et al.. (2009). Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations. The AAPS Journal. 11(2). 238–241. 208 indexed citations
4.
Viswanathan, C.T., Surendra K. Bansal, Brian Booth, et al.. (2007). Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays. Pharmaceutical Research. 24(10). 1962–1973. 667 indexed citations breakdown →
5.
Shah, Vinod P., Kamal K. Midha, John W. A. Findlay, et al.. (2000). Bioanalytical Method Validation—A Revisit with a Decade of Progress. Pharmaceutical Research. 17(12). 1551–1557. 1353 indexed citations breakdown →
6.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1994). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. The Journal of Clinical Pharmacology. 34(2). 111–119. 37 indexed citations
7.
Shiu, Gerald K., et al.. (1993). Effects of Humidity and Temperature on In Vitro Dissolution of Carbamazepine Tablets. Journal of Pharmaceutical Sciences. 82(10). 1002–1005. 26 indexed citations
8.
Gallo, James M., et al.. (1992). Pharmacokinetic Evaluation of Drug Interactions with Anti-HIV Drugs, II: Effect of 2′,3′-Dideoxyinosine (ddI) on Zidovudine Kinetics in Monkeys. AIDS Research and Human Retroviruses. 8(2). 277–283. 12 indexed citations
9.
Shiu, Gerald K., et al.. (1992). High performance liquid chromatographic analysis of six conjugated and unconjugated estrogens in serum. Biomedical Chromatography. 6(6). 265–268. 4 indexed citations
10.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clinical Pharmacology & Therapeutics. 51(4). 465–473. 141 indexed citations
11.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Journal of Pharmaceutical Sciences. 81(6). 605–610. 49 indexed citations
12.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Pharmaceutical Research. 9(6). 826–833. 41 indexed citations
13.
Shah, Vinod P., K.K. Midha, I.J. McGilveray, et al.. (1991). Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. European Journal of Drug Metabolism and Pharmacokinetics. 16(4). 249–255. 556 indexed citations breakdown →
14.
Qian, Mingxin, Timothy S. Finco, Minesh P. Mehta, C.T. Viswanathan, & James M. Gallo. (1991). Pharmacokinetic Evaluation of Drug Interactions with Zidovudine. I: Probenecid and Zidovudine in Monkeys. Journal of Pharmaceutical Sciences. 80(11). 1007–1011. 19 indexed citations
15.
Koup, Jeffrey R., Judy Williams‐Warren, C.T. Viswanathan, Allan Weber, & Arnold L. Smith. (1986). Pharmacokinetics of Rifampin in Children II. Oral Bioavailability. Therapeutic Drug Monitoring. 8(1). 17–22. 27 indexed citations
16.
Lockard, Joan S., C.T. Viswanathan, & René H. Levy. (1985). Diurnal oscillations of CSF valproate in monkey. Life Sciences. 36(13). 1281–1285. 7 indexed citations
17.
Rapaka, Rao S., Jeri S. Roth, C.T. Viswanathan, et al.. (1982). Improved method for the analysis of furosemide in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 227(2). 463–469. 25 indexed citations
18.
Viswanathan, C.T. & René H. Levy. (1981). Plasma Protein Binding Interaction Between Valproic and Salicylic Acids in Rhesus Monkeys. Journal of Pharmaceutical Sciences. 70(11). 1279–1281. 9 indexed citations
19.
Viswanathan, C.T., Harold E. Booker, & Peter G. Welling. (1978). Bioavailability of Oral and Intramuscular Phenobarbital. The Journal of Clinical Pharmacology. 18(2-3). 100–105. 35 indexed citations
20.
Rudy, Thomas A. & C.T. Viswanathan. (1975). Effect of Central Cholinergic Blockade on the Hyperthermia Evoked by Prostaglandin E1 Injected Into the Rostral Hypothalamus of the Rat. Canadian Journal of Physiology and Pharmacology. 53(2). 321–324. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerome P. Skelly Breakdown of academic impact, for papers by Avraham Yacobi Breakdown of academic impact, for papers by Kamal K. Midha Breakdown of academic impact, for papers by Iain J. McGilveray Breakdown of academic impact, for papers by C. E. Cook Breakdown of academic impact, for papers by R.D. McDowall Breakdown of academic impact, for papers by Mohammed Jemal Breakdown of academic impact, for papers by C.M. Chavez-Eng Breakdown of academic impact, for papers by U. Kristina Walle Breakdown of academic impact, for papers by Eric Woolf
Rankless by CCL
2026